A detailed history of Laurel Wealth Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 10,983 shares of GILD stock, worth $1.03 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,983
Previous 11,013 0.27%
Holding current value
$1.03 Million
Previous $680,000 38.68%
% of portfolio
0.09%
Previous 0.07%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $1,869 - $2,684
-30 Reduced 0.27%
10,983 $943,000
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $2,977 - $3,400
-50 Reduced 0.45%
11,013 $680,000
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $62,222 - $70,080
-1,078 Reduced 8.88%
11,063 $684,000
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $20,967 - $26,273
362 Added 3.07%
12,141 $722,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $292,673 - $332,190
4,511 Added 62.07%
11,779 $855,000
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $119,946 - $129,409
-1,772 Reduced 19.6%
7,268 $508,000
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $4,760 - $5,201
75 Added 0.84%
9,040 $623,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $104,340 - $119,051
-1,739 Reduced 16.25%
8,965 $579,000
Q4 2020

Mar 03, 2021

SELL
$56.65 - $64.55 $13,482 - $15,362
-238 Reduced 2.18%
10,704 $623,000
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $145,003 - $182,316
2,335 Added 27.13%
10,942 $691,000
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $146,922 - $170,604
-2,031 Reduced 19.09%
8,607 $662,000
Q1 2020

May 15, 2020

BUY
$62.63 - $80.22 $115,364 - $147,765
1,842 Added 20.94%
10,638 $795,000
Q4 2019

Feb 13, 2020

SELL
$61.62 - $67.78 $252,950 - $278,236
-4,105 Reduced 31.82%
8,796 $572,000
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $101,391 - $111,918
1,622 Added 14.38%
12,901 $818,000
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $32,048 - $35,938
518 Added 4.81%
11,279 $762,000
Q1 2019

May 16, 2019

BUY
$62.53 - $70.05 $81,726 - $91,555
1,307 Added 13.82%
10,761 $700,000
Q4 2018

Feb 13, 2019

SELL
$60.54 - $79.0 $152,318 - $198,764
-2,516 Reduced 21.02%
9,454 $591,000
Q3 2018

Nov 15, 2018

SELL
$71.28 - $78.92 $81,686 - $90,442
-1,146 Reduced 8.74%
11,970 $924,000
Q2 2018

Aug 20, 2018

BUY
$64.88 - $75.68 $183,480 - $214,023
2,828 Added 27.49%
13,116 $929,000
Q1 2018

May 16, 2018

BUY
$72.84 - $88.8 $40,936 - $49,905
562 Added 5.78%
10,288 $775,000
Q4 2017

Feb 15, 2018

BUY
$71.15 - $83.52 $76,842 - $90,201
1,080 Added 12.49%
9,726 $696,000
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $19,037 - $22,564
264 Added 3.15%
8,646 $699,000
Q2 2017

Aug 15, 2017

BUY
N/A
8,382
8,382 $592,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Laurel Wealth Advisors, Inc. Portfolio

Follow Laurel Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.